Literature DB >> 993587

Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.

H J Bertrams, E K Kuwert.   

Abstract

Tissue typing was performed on 1000 unrelated multiple sclerosis (MS) patients and 1000 unrelated healthy controls. In addition, segregation analysis of HLA antigens and haplotypes in 36 MS families was done. The following results were observed: HLA-A3 and HLA-B7 were found significantly more often in MS individuals; haplotype HLA-A3-B7 was observed significantly more often in MS patients than in healthy indiciduals of the same population; the association between HLA-A3 and HLA-B7 was signigicantly stronger in MS patients than in controls; the haplotype HLA-A3-B7 shows a common segregation with the disease multiple sclerosis (p = 0.02); and the hypothetical "MS-disease-susceptibility-gene" may be located between the second locus and the HLA region and the MLC (mixed lymphocyte culture)-histocompatibility-determinant-region on chromosome No. 6.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993587

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Genetic loci of components of the classical and alternate pathway of complement activation: a new dimension of the immunogenetic linkage group (HLA) on chromosome 6 in man.

Authors:  C Rittner
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

Review 3.  The HLA linkage group and disease susceptibility.

Authors:  J Bertrams; M Spitznas
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-07-26

4.  HLA antigens in chronic inflammatory demyelinating polyneuropathy.

Authors:  D J Feeney; J D Pollard; J G McLeod; G J Stewart; T J Doran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

Review 5.  Multiple sclerosis: autoimmunity and viruses.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

6.  Histocompatibility antigens (HLA) in multiple sclerosis in Iran.

Authors:  J Lotfi; B Nikbin; I Derakhshan; Z Aghai; F Ala
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-08       Impact factor: 10.154

Review 7.  Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.

Authors:  Carol Chase Huizar; Itay Raphael; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2020-09-20       Impact factor: 4.868

8.  Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.

Authors:  D C Poskanzer; P I Terasaki; L B Prenney; J L Sheridan; M S Park
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

9.  HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection.

Authors:  G Lamoureux; P Duquette; Y Lapierre; B Cosgrove; G Bourret; L Labrie
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

10.  Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated.

Authors:  E Kahana; N Zilber; J H Abramson; V Biton; Y Leibowitz; O Abramsky
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.